美国 · SEC FORM 4
BIOLIFE SOLUTIONS INC
BLFS · Nasdaq · CIK 0000834365 · Healthcare
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
49 同一窗口内观察到的 Form 4 交易行
3 sales · 46 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-10-19 · Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P..
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- —
- 3M
- —
- 6M
- —
- 12M
- —
波动率与流动性
- 波动率
- —
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -4.8%
- ROE
- -1.2%
- 细分行业
- Electromedical & Electrotherapeutic Apparatus
市场数据
价格数据截至:2026-10-18 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:利润率, ROE · 财年截止日:2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 3,999,252
- 上期报告
- 3,884,193
- 日均成交量
- 923,759
- 回补天数
- 4.3
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-10-19 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 927,165 | USD 11.19 | USD 10,374,976 | SEC 申报 ↗ |
| 2023-08-09 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 58,465 | USD 13.20 | USD 771,738 | SEC 申报 ↗ |
| 2023-05-22 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 24,973 | USD 21.86 | USD 545,910 | SEC 申报 ↗ |
| 2023-05-19 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 50,000 | USD 22.55 | USD 1,127,500 | SEC 申报 ↗ |
| 2023-05-18 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 30,000 | USD 21.76 | USD 652,800 | SEC 申报 ↗ |
| 2023-05-17 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 30,027 | USD 21.30 | USD 639,575 | SEC 申报 ↗ |
| 2023-05-16 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 15,000 | USD 20.19 | USD 302,850 | SEC 申报 ↗ |
| 2020-11-24 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 1,600,000 | USD 22.50 | USD 36,000,000 | SEC 申报 ↗ |
| 2020-07-02 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 305,583 | USD 14.50 | USD 4,430,954 | SEC 申报 ↗ |
| 2020-07-01 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 685,000 | USD 14.50 | USD 9,932,500 | SEC 申报 ↗ |
| 2020-05-22 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 476,191 | USD 10.50 | USD 5,000,006 | SEC 申报 ↗ |
| 2020-05-14 | Casdin Capital, LLC; Casdin Eli; Casdin Partners GP, LLC; Casdin Partners Master Fund, L.P. | 买入 (P) | Common Stock, par value $.001 per share | 1,904,762 | USD 10.50 | USD 20,000,001 | SEC 申报 ↗ |
Form 4 申报证据
123 transaction lines in the latest 365-day window; 1,276 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Wichterman Troy | 代扣税 (F) | Common Stock | 95,933 | USD 38.61 | USD 3,703,973 | SEC 申报 ↗ |
| 2026-10-06 | Wichterman Troy | D (D) | Common Stock | 256,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Wichterman Troy | 奖励/授予 (A) | Common Stock | 138,504 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Wichterman Troy | 代扣税 (F) | Common Stock | 95,933 | USD 38.61 | USD 3,703,973 | SEC 申报 ↗ |
| 2026-10-06 | Wichterman Troy | D (D) | Common Stock | 256,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Wichterman Troy | 奖励/授予 (A) | Common Stock | 138,504 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Werner Sean | 代扣税 (F) | Common Stock | 71,226 | USD 38.61 | USD 2,750,036 | SEC 申报 ↗ |
| 2026-10-06 | Werner Sean | D (D) | Common Stock | 69,979 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Werner Sean | 奖励/授予 (A) | Common Stock | 94,070 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Mathew Aby J. | 代扣税 (F) | Common Stock | 70,000 | USD 38.61 | USD 2,702,700 | SEC 申报 ↗ |
| 2026-10-06 | Mathew Aby J. | D (D) | Common Stock | 404,608 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Mathew Aby J. | 奖励/授予 (A) | Common Stock | 86,030 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | MOORE TIMOTHY L. | D (D) | Common Stock | 44,943 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Hunt Anthony | D (D) | Common Stock | 15,046 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | GOSWAMI JOYDEEP | D (D) | Common Stock | 53,156 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Ellingson Rachel | D (D) | Common Stock | 57,995 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | DuRoss Amy | D (D) | Common Stock | 26,857 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | DE GREEF RODERICK | 代扣税 (F) | Common Stock | 364,872 | USD 38.61 | USD 14,087,708 | SEC 申报 ↗ |
| 2026-10-06 | DE GREEF RODERICK | D (D) | Common Stock | 826,454 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | DE GREEF RODERICK | 奖励/授予 (A) | Common Stock | 463,130 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Coste Catherine | D (D) | Common Stock | 13,871 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Berard Todd | 代扣税 (F) | Common Stock | 46,170 | USD 38.61 | USD 1,782,624 | SEC 申报 ↗ |
| 2026-10-06 | Berard Todd | D (D) | Common Stock | 194,786 | USD — | USD — | SEC 申报 ↗ |
| 2026-10-06 | Berard Todd | 奖励/授予 (A) | Common Stock | 78,390 | USD — | USD — | SEC 申报 ↗ |
| 2026-09-18 | Wichterman Troy | 代扣税 (F) | Common Stock | 937 | USD 36.69 | USD 34,379 | SEC 申报 ↗ |
| 2026-09-18 | Werner Sean | 代扣税 (F) | Common Stock | 421 | USD 36.69 | USD 15,446 | SEC 申报 ↗ |
| 2026-09-18 | Mathew Aby J. | 代扣税 (F) | Common Stock | 564 | USD 36.69 | USD 20,693 | SEC 申报 ↗ |
| 2026-09-18 | DE GREEF RODERICK | 代扣税 (F) | Common Stock | 2,775 | USD 36.69 | USD 101,815 | SEC 申报 ↗ |
| 2026-09-18 | Berard Todd | 代扣税 (F) | Common Stock | 470 | USD 36.69 | USD 17,244 | SEC 申报 ↗ |
| 2026-09-08 | Wichterman Troy | 代扣税 (F) | Common Stock | 1,026 | USD 35.38 | USD 36,300 | SEC 申报 ↗ |
| 2026-09-08 | Mathew Aby J. | 代扣税 (F) | Common Stock | 627 | USD 35.38 | USD 22,183 | SEC 申报 ↗ |
| 2026-09-08 | Berard Todd | 代扣税 (F) | Common Stock | 356 | USD 35.38 | USD 12,595 | SEC 申报 ↗ |
| 2026-07-17 | Werner Sean | 代扣税 (F) | Common Stock | 275 | USD 29.15 | USD 8,016 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BLFS |
| CIK | 0000834365 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 1,276 transaction lines from 2020-01-06 to 2026-10-06 12 P purchase lines · 773 S sale lines · 491 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.